Clinical trial
Neovas Versus DCB for Coronary de Novo Lesions in Patients With STEMI: a Prospective Observational Clinical Trial
NCT04565561 is registered in ClinicalTrials.gov with Shenzhen People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neovas Versus DCB for Coronary de Novo Lesions in Patients With STEMI: a Prospective Observational Clinical Trial
- Lead sponsor
- Shenzhen People's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 1, 2020
- Completion date
- December 1, 2022
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.